After the market close on 20 November, ELAN Corporation revised its ordinary profit forecast for the current fiscal year upward, changing it from ¥5.0 billion to ¥5.75 billion, and raised its expected profit growth rate. Net income, however, was revised sharply downward, changing from the previous forecast of ¥3.2 billion to ¥1.5 billion. Ordinary profit for the second half is expected to be ¥3.15 billion.
ELAN Corporation announced that it had revised its consolidated ordinary profit forecast for the current fiscal year upward, changing it from the previous forecast of ¥5.0 billion to ¥5.75 billion. The previous fiscal year's actual result was ¥4.18 billion, and the profit growth rate is expected to increase from 19.5% to 37.4%. Revenue has remained solid, supported by applications from facilities that have introduced CS Set, and the overall profit level is cited as the reason for the upward revision. The upward revision to ordinary profit also affects the outlook for the second half.
At the same time, consolidated net income for the full fiscal year was revised downward by 53.1%, changing from the previous forecast of ¥3.2 billion to ¥1.5 billion, resulting in an expected 45.8% decline in profit. Extraordinary losses, including impairment losses on investment securities and goodwill impairment at a subsidiary, are having an impact, and net income is expected to fall short of the previous forecast.
The ordinary profit forecast for the second half was revised upward, changing from the previous forecast of ¥2.4 billion to ¥3.15 billion, which is also an increase from ¥2.15 billion in the same period of the previous year. The profit growth rate is calculated to increase from 11.9% to 46.8%. The outlook for the second half is based on the plan following the upward revision, with solid revenue and improved cost control expected to contribute.
This revision was prepared by Kabutan News based on company materials and reflects information available as of the announcement date. Depending on developments going forward, actual results may become a focus of attention.